Cargando…

Mechanism and Pathways of Inhibitor Binding to the Human ACE2 Receptor for SARS-CoV1/2

Detalles Bibliográficos
Autores principales:	Bhattarai, Apurba, Pawnikar, Shristi, Miao, Yinglong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Biophysical Society 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879778/ http://dx.doi.org/10.1016/j.bpj.2020.11.1393

Ejemplares similares

Mechanism of ligand recognition by human ACE2 receptor
por: Bhattarai, Apurba, et al.
Publicado: (2020)

Binding Analysis Using Accelerated Molecular Dynamics Simulations and Future Perspectives
por: Pawnikar, Shristi, et al.
Publicado: (2022)

Mechanism of Peptide Agonist Binding in CXCR4 Chemokine Receptor
por: Pawnikar, Shristi, et al.
Publicado: (2022)

Peptide Inhibitors of the Interaction of the SARS-CoV-2 Receptor-Binding Domain with the ACE2 Cell Receptor
por: Bibilashvili, R. Sh., et al.
Publicado: (2021)

Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor
por: Yang, Jinsung, et al.
Publicado: (2020)

Distinct Differences in the Interactions of Receptor Binding Domains of SARS-CoV-2 and SARS-CoV with Human ACE2
por: Acharya, Atanu, et al.
Publicado: (2021)

SARS-CoV-2 receptor ACE2 gene expression and RAAS inhibitors
por: Milne, Stephen, et al.
Publicado: (2020)

Inferring the stabilization effects of SARS-CoV-2 variants on the binding with ACE2 receptor
por: Miotto, Mattia, et al.
Publicado: (2022)

Multiformin-Type Azaphilones Prevent SARS-CoV-2 Binding to ACE2 Receptor
por: Jansen-Olliges, Linda, et al.
Publicado: (2022)

Azelastine inhibits viropexis of SARS-CoV-2 spike pseudovirus by binding to SARS-CoV-2 entry receptor ACE2
por: Ge, Shuai, et al.
Publicado: (2021)

On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS-CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2
por: Corrêa Giron, Carolina, et al.
Publicado: (2020)

Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2–ACE2 Receptor Interactions
por: Day, Christopher J., et al.
Publicado: (2021)

Hold your horses: The receptor-binding domains of SARS-CoV-2, SARS-CoV, and hCoV-NL63 bind equine ACE2
por: Nawrath, Philipp, et al.
Publicado: (2022)

Structural insights into the binding of SARS-CoV-2, SARS-CoV, and hCoV-NL63 spike receptor-binding domain to horse ACE2
por: Lan, Jun, et al.
Publicado: (2022)

Sphingosine prevents binding of SARS–CoV-2 spike to its cellular receptor ACE2
por: Edwards, Michael J., et al.
Publicado: (2020)

Stroke increases the expression of ACE2, the SARS-CoV-2 binding receptor, in murine lungs
por: Singh, Vikramjeet, et al.
Publicado: (2021)

Plastic Antibodies Mimicking the ACE2 Receptor for Selective Binding of SARS‐CoV‐2 Spike
por: Batista, Alex D., et al.
Publicado: (2022)

Computational optimization of the SARS-CoV-2 receptor-binding-motif affinity for human ACE2
por: Polydorides, Savvas, et al.
Publicado: (2021)

Author Correction: Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor
por: Yang, Jinsung, et al.
Publicado: (2021)

The molecular basis for SARS-CoV-2 binding to dog ACE2
por: Zhang, Zengyuan, et al.
Publicado: (2021)

SARS-CoV-2 spike and ACE2 entanglement-like binding
por: Pregnolato, Massimo, et al.
Publicado: (2023)

Trimeric receptor-binding domain of SARS-CoV-2 acts as a potent inhibitor of ACE2 receptor-mediated viral entry
por: Basavarajappa, Shrikanth C., et al.
Publicado: (2022)

Oral cancer and ACE2 receptor of SARS-CoV-2
por: Martelli-Júnior, Hercílio, et al.
Publicado: (2020)

The glycosylation in SARS-CoV-2 and its receptor ACE2
por: Gong, Yanqiu, et al.
Publicado: (2021)

ACE2-Independent Alternative Receptors for SARS-CoV-2
por: Lim, Suhyeon, et al.
Publicado: (2022)

Efficient purification and assembly of ribonucleoprotein complex for interaction analysis by MST assay coupled with GaMD simulations
por: Gao, Yunrong, et al.
Publicado: (2021)

Mechanism of tethered agonist-mediated signaling by polycystin-1
por: Pawnikar, Shristi, et al.
Publicado: (2022)

Structural Basis for Binding of Allosteric Drug Leads in the Adenosine A(1) Receptor
por: Miao, Yinglong, et al.
Publicado: (2018)

Potential inhibitor for blocking binding between ACE2 and SARS-CoV-2 spike protein with mutations
por: Tsai, Ming-Shao, et al.
Publicado: (2022)

Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2
por: Wang, Shunxin, et al.
Publicado: (2008)

Does SARS-CoV-2 Bind to Human ACE2 More Strongly Than Does SARS-CoV?
por: Nguyen, Hoang Linh, et al.
Publicado: (2020)

Spike Proteins of SARS-CoV and SARS-CoV-2 Utilize Different Mechanisms to Bind With Human ACE2
por: Xie, Yixin, et al.
Publicado: (2020)

Development of a SARS-CoV-2-derived receptor-binding domain-based ACE2 biosensor
por: Suh, Jung-Soo, et al.
Publicado: (2021)

Possible host-adaptation of SARS-CoV-2 due to improved ACE2 receptor binding in mink
por: Welkers, Matthijs R A, et al.
Publicado: (2021)

Biochemical Characterization of SARS-CoV-2 Spike RBD Mutations and Their Impact on ACE2 Receptor Binding
por: Hoter, Abdullah, et al.
Publicado: (2022)

Broad host range of SARS-CoV-2 and the molecular basis for SARS-CoV-2 binding to cat ACE2
por: Wu, Lili, et al.
Publicado: (2020)

Revealing the Mechanism of SARS-CoV-2 Spike Protein Binding With ACE2
Publicado: (2020)

Identifying compounds that prevent the binding of the SARS-CoV-2 S-protein to ACE2
por: Benítez-Cardoza, Claudia Guadalupe, et al.
Publicado: (2021)

Cross-species binding spectrum of ACE2 to SARS-CoV-2 RBD
por: Liao, Xihao, et al.
Publicado: (2022)

Mechanism and evolution of human ACE2 binding by SARS-CoV-2 spike
por: Wrobel, Antoni G.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j0bt48oib6uihv75i453n8munh